Table 3. Post-treatment clinical, echocardiographic and CT angiographic measures in acute pulmonary embolism patients with or without syncope.
| Syncope absent (n=448) | Syncope present (n=193) | p | |||||||
| n | % | Median | IQR | n | % | Median | IQR | ||
| Pleural effusion* | 52 | 11.60 | 35 | 18.1 | 0.397 | ||||
| Pleural infarct* | 45 | 10.04 | 29 | 15.02 | 0.517 | ||||
| Major bleeding | 21 | 4.68 | 16 | 8.29 | 0.061 | ||||
| Minor bleeding | 13 | 2.90 | 20 | 10.36 | <0.001 | ||||
| In-hospital mortality | 27 | 6.02 | 25 | 12.95 | 0.007 | ||||
| Long-term mortality | 88 | 19.64 | 46 | 23.83 | 0.159 | ||||
| Systolic blood pressure* (mmHg) | 124 | 114-133 | 124 | 112-134 | 0.470 | ||||
| Heart rate* (bpm) | 82 | 75-91 | 81 | 74-90 | 0.514 | ||||
| SPO2* | 95 | 94-97 | 94 | 93-96 | 0.058 | ||||
| Shock index* | 0.67 | 0.59-0.75 | 0.66 | 0.58-0.75 | 0.764 | ||||
| PASP* (mmHg) | 35 | 30-40 | 35 | 30-40 | 0.460 | ||||
| TAPSE* (cm) | 2.3 | 2-2. 5 | 2.3 | 2.1-2.5 | 0.264 | ||||
| RV-St* (cm/sn) | 14 | 12-16 | 13.8 | 12-15 | 0.587 | ||||
| Qanadli score* | 9 | 5-14 | 8 | 5-13 | 0.770 | ||||
| RV/LV ratio at CT* | 0.91 | 0.83-0.97 | 0.91 | 0.83-1 | 0.441 | ||||
| RA/LA ratio at CT* | 1.02 | 0.92-1.21 | 1 | 0.92-1.18 | 0.865 | ||||
| MPA diameter at CT* (mm) | 27.3 | 24.4-30.2 | 27.3 | 24.7-30.1 | 0.687 | ||||
| Hospitalization duration (days) | 10 | 7-13 | 10 | 7-14 | 0.650 | ||||
| Follow-up (days) | 770 | 284-1467 | 637 | 233-1098 | 0.025 | ||||
| CT: Computed tomography; * At discharge; IQR: Interquartile range; SpO2: Blood oxygen saturation; PASP: Pulmonary artery systolic pressure; TAPSE: Tricuspid annular plane systolic excursion; RV-St: Right ventricle systolic motion; RV: Right ventricle; LV: Left ventricle; RA: Right atrium; LA: Left atrium; MPA: Main pulmonary artery. | |||||||||